Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336115
Status:
UNKNOWN
Last Update Posted:
2007-10-23
First Post:
2006-06-09
Brief Title:
The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients
Sponsor:
Queen Elizabeth II Health Sciences Centre
Organization:
Queen Elizabeth II Health Sciences Centre
Study Overview
Official Title:
Safety and Immunogenicity of Adult Formulation Tetanus and Diphtheria Toxoids Adsorbed Combined With Acellular Pertussis Tdap Vaccine Following Blood and Morrow Transplantation in Adults
Status:
UNKNOWN
Status Verified Date:
2007-10
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if pertussis whooping cough vaccine is safe and produces an appropriate immune response against pertussis in blood and marrow transplant patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None